Butterfly Network (BFLY) Change in Account Payables (2020 - 2026)
Butterfly Network (BFLY) reported Change in Account Payables of -$2.6 million for Q1 2026, down 34.16% on a YoY basis from -$4.0 million in Q1 2025, and down 223.62% sequentially from $2.1 million in Q4 2025.
Butterfly Network (BFLY) Change in Account Payables (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Change in Account Payables data on file, last reported at -$2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 34.16% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2026 stood at $522000.0 (up 114.85% YoY), and the FY2025 full-year result was $1.2 million, up 242.09% from the prior year.
- Change in Account Payables eased to -$2.6 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.3 million in Q4 2022 to a low of -$3.2 million in Q1 2022.
- A 5-year average of -$173411.8 and a median of -$298000.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 939.77% in 2022 and slumped 380.23% in 2025, its largest moves.
- Tracing BFLY's Change in Account Payables over 5 years: stood at $4.3 million in 2022, then plunged by 168.41% to -$3.0 million in 2023, then soared by 120.19% to $599000.0 in 2024, then surged by 256.93% to $2.1 million in 2025, then slumped by 223.62% to -$2.6 million in 2026.
- Business Quant data shows BFLY's Change in Account Payables at -$2.6 million in Q1 2026, $2.1 million in Q4 2025, and -$16000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | -2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.64 Mn |
| Mar 31, 2026 | -2.64 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | 599,000.00 |
| Dec 31, 2024 | 599,000.00 |
| Sep 30, 2024 | -853,000.00 |
| Sep 30, 2024 | -853,000.00 |
| Jun 30, 2024 | -1.29 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | 703,000.00 |
| Mar 31, 2024 | 703,000.00 |
| Dec 31, 2023 | -2.97 Mn |
| Dec 31, 2023 | -2.97 Mn |